cobimetinib
Sign in to saveAlso known as GDC-0973, XL-518, XL518, GDC 0973, RG 7420, Xl 518, RG7420, GDC0973
Cobimetinib, sold under the brand name Cotellic, is an anti-cancer medication used to treat melanoma and histiocytic neoplasms. Cobimetinib is a MEK inhibitor. Cobimetinib is marketed by Genentech.
~3 min read
Encyclopedic overview
5 sectionsContents
- Medical use
- Adverse effects
- History
- Research
- References
Cobimetinib, sold under the brand name Cotellic, is an anti-cancer medication used to treat melanoma and histiocytic neoplasms. Cobimetinib is a MEK inhibitor. Cobimetinib is marketed by Genentech.
The most common side effects include diarrhea, rash, nausea (feeling sick), vomiting, pyrexia (fever), photosensitivity (light sensitivity) reaction, abnormal results for certain liver function tests (increased levels of alanine aminotransferase, aspartate aminotransferase) and abnormal results for an enzyme related to muscle breakdown (creatine phosphokinase).
Excerpted from Wikipedia’s “cobimetinib” article, available under the CC BY-SA 4.0 licence.